Your browser doesn't support javascript.
loading
Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial.
Oza, Amit M; Cibula, David; Benzaquen, Ana Oaknin; Poole, Christopher; Mathijssen, Ron H J; Sonke, Gabe S; Colombo, Nicoletta; Spacek, Jirí; Vuylsteke, Peter; Hirte, Holger; Mahner, Sven; Plante, Marie; Schmalfeldt, Barbara; Mackay, Helen; Rowbottom, Jacqui; Lowe, Elizabeth S; Dougherty, Brian; Barrett, J Carl; Friedlander, Michael.
Afiliação
  • Oza AM; Princess Margaret Cancer Centre, Toronto, ON, Canada. Electronic address: amit.oza@uhn.ca.
  • Cibula D; General University Hospital, Prague, Czech Republic.
  • Benzaquen AO; Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain.
  • Poole C; University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK.
  • Mathijssen RH; Erasmus MC Cancer Institute, Rotterdam, Netherlands.
  • Sonke GS; Netherlands Cancer Institute, Amsterdam, Netherlands.
  • Colombo N; University of Milan-Bicocca, European Institute of Oncology, Milan, Italy.
  • Spacek J; University Hospital, Hradec Kralove, Czech Republic.
  • Vuylsteke P; Sainte-Elisabeth Hospital, Namur, Belgium.
  • Hirte H; Juravinski Cancer Centre, Hamilton, ON, Canada.
  • Mahner S; University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Plante M; Laval University, Quebec, Canada.
  • Schmalfeldt B; Technical University Munich, Munich, Germany.
  • Mackay H; Princess Margaret Cancer Centre, Toronto, ON, Canada.
  • Rowbottom J; AstraZeneca, Macclesfield, UK.
  • Lowe ES; AstraZeneca, Wilmington, DE, USA.
  • Dougherty B; AstraZeneca, Waltham, MA, USA.
  • Barrett JC; AstraZeneca, Waltham, MA, USA.
  • Friedlander M; Prince of Wales Clinical School, University of New South Wales, Sydney, NSW, Australia.
Lancet Oncol ; 16(1): 87-97, 2015 Jan.
Article em En | MEDLINE | ID: mdl-25481791
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Ftalazinas / Piperazinas / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias Císticas, Mucinosas e Serosas / Inibidores Enzimáticos / Inibidores de Poli(ADP-Ribose) Polimerases / Recidiva Local de Neoplasia / Antineoplásicos Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Ftalazinas / Piperazinas / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias Císticas, Mucinosas e Serosas / Inibidores Enzimáticos / Inibidores de Poli(ADP-Ribose) Polimerases / Recidiva Local de Neoplasia / Antineoplásicos Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2015 Tipo de documento: Article